Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1986 Dec;54(6):885–889. doi: 10.1038/bjc.1986.257

A low pH enzyme linked immunoassay using two monoclonal antibodies for the serological detection and monitoring of breast cancer.

B Dhokia, D Pectasides, C Self, N A Habib, M Hershman, C B Wood, A J Munro, A A Epenetos
PMCID: PMC2001585  PMID: 3801285

Abstract

A new, simple and sensitive low pH ELISA method has been developed to measure serum levels of tumour associated antigens detectable by monoclonal antibodies HMFG1 and HMFG2. We examined sera from healthy controls, patients with neoplastic and non-neoplastic conditions of breast, liver and gastrointestinal tract. The majority of patients with metastatic breast cancer had elevated serum antigens (69% HMFG1, 72% HMFG2) compared to healthy controls (6.3% HMFG1, 3.0% HMFG2) or patients with benign breast disease (17% HMFG1, 4% HMFG2). There was no discrimination using these assays between patients with neoplastic and non-neoplastic conditions of liver and gastrointestinal tract. This new method promises to be of value in the assessment and management of patients with breast cancer.

Full text

PDF
889

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arklie J., Taylor-Papadimitrious J., Bodmer W., Egan M., Millis R. Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer. 1981 Jul 15;28(1):23–29. doi: 10.1002/ijc.2910280105. [DOI] [PubMed] [Google Scholar]
  2. Bast R. C., Jr, Klug T. L., St John E., Jenison E., Niloff J. M., Lazarus H., Berkowitz R. S., Leavitt T., Griffiths C. T., Parker L. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983 Oct 13;309(15):883–887. doi: 10.1056/NEJM198310133091503. [DOI] [PubMed] [Google Scholar]
  3. Burchell J., Durbin H., Taylor-Papadimitriou J. Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. J Immunol. 1983 Jul;131(1):508–513. [PubMed] [Google Scholar]
  4. Burchell J., Wang D., Taylor-Papadimitriou J. Detection of the tumour-associated antigens recognized by the monoclonal antibodies HMFG-1 and 2 in serum from patients with breast cancer. Int J Cancer. 1984 Dec 15;34(6):763–768. doi: 10.1002/ijc.2910340605. [DOI] [PubMed] [Google Scholar]
  5. Ceriani R. L., Sasaki M., Sussman H., Wara W. M., Blank E. W. Circulating human mammary epithelial antigens in breast cancer. Proc Natl Acad Sci U S A. 1982 Sep;79(17):5420–5424. doi: 10.1073/pnas.79.17.5420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Coombes R. C., Powles T. J., Gazet J. C., Ford H. T., McKinna A., Abbott M., Gehrke C. W., Keyser J. W., Mitchell P. E., Patel S. Screening for metastases in breast cancer: an assessment of biochemical and physical methods. Cancer. 1981 Jul 15;48(2):310–315. doi: 10.1002/1097-0142(19810715)48:2<310::aid-cncr2820480216>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  7. Cove D. H., Woods K. L., Smith S. C., Burnett D., Leonard J., Grieve R. J., Howell A. Tumour markers in breast cancer. Br J Cancer. 1979 Nov;40(5):710–718. doi: 10.1038/bjc.1979.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Epenetos A. A., Munro A. J., Tucker D. F., Gregory W., Duncan W., MacDougall R. H., Faux M., Travers P., Bodmer W. F. Monoclonal antibody assay of serum placental alkaline phosphatase in the monitoring of testicular tumours. Br J Cancer. 1985 May;51(5):641–644. doi: 10.1038/bjc.1985.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goodall A. B., Evans C. J., Trivedi D., Coombes R. C., Chantler S. M. Detection of Ca antigen in sera from normal individuals and patients with benign and malignant breast disease. Br J Cancer. 1985 Aug;52(2):177–182. doi: 10.1038/bjc.1985.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hayes D. F., Sekine H., Ohno T., Abe M., Keefe K., Kufe D. W. Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients. J Clin Invest. 1985 May;75(5):1671–1678. doi: 10.1172/JCI111875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ishikawa E., Imagawa M., Hashida S., Yoshitake S., Hamaguchi Y., Ueno T. Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining. J Immunoassay. 1983;4(3):209–327. doi: 10.1080/15321818308057011. [DOI] [PubMed] [Google Scholar]
  12. Lamoureux G., Mandeville R., Poisson R., Legault-Poisson S., Jolicoeur R. Biologic markers and breast cancer: a multiparametric study--1. Increased serum protein levels. Cancer. 1982 Feb 1;49(3):502–512. doi: 10.1002/1097-0142(19820201)49:3<502::aid-cncr2820490318>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  13. Lange P. H., McIntire K. R., Waldmann T. A., Hakala T. R., Fraley E. E. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer. N Engl J Med. 1976 Nov 25;295(22):1237–1240. doi: 10.1056/NEJM197611252952207. [DOI] [PubMed] [Google Scholar]
  14. Papsidero L. D., Nemoto T., Croghan G. A., Chu T. M. Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22. Cancer Res. 1984 Oct;44(10):4653–4657. [PubMed] [Google Scholar]
  15. Taylor-Papadimitriou J., Peterson J. A., Arklie J., Burchell J., Ceriani R. L., Bodmer W. F. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer. 1981 Jul 15;28(1):17–21. doi: 10.1002/ijc.2910280104. [DOI] [PubMed] [Google Scholar]
  16. Thompson C. H., Jones S. L., Whitehead R. H., McKenzie I. F. A human breast tissue-associated antigen detected by a monoclonal antibody. J Natl Cancer Inst. 1983 Mar;70(3):409–419. [PubMed] [Google Scholar]
  17. Waalkes T. P., Gehrke C. W., Tormey D. C., Woo K. B., Kuo K. C., Synder J., Hansen H. Biologic markers in breast carcinoma. IV. Serum fucose-protein ratio. Comparisons with carcinoembryonic antigen and human chorionic gonadotrophin. Cancer. 1978 May;41(5):1871–1882. doi: 10.1002/1097-0142(197805)41:5<1871::aid-cncr2820410531>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  18. Wang D. Y., Knyba R. E., Bulbrook R. D., Millis R. R., Hayward J. L. Serum carcinoembryonic antigen in the diagnosis and prognosis of women with breast cancer. Eur J Cancer Clin Oncol. 1984 Jan;20(1):25–31. doi: 10.1016/0277-5379(84)90030-0. [DOI] [PubMed] [Google Scholar]
  19. Wilkinson M. J., Howell A., Harris M., Taylor-Papadimitriou J., Swindell R., Sellwood R. A. The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas. Int J Cancer. 1984 Mar 15;33(3):299–304. doi: 10.1002/ijc.2910330304. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES